Audited by PwC

Enzymes are produced by the fermentation of microorganisms. Within BioBusiness we use the same type of fermentation technology to produce proteins that are used, for example, in the pharmaceutical industry and in household applications. We sell microorganisms for various applications in a range of industries. We see a lot of opportunities in BioBusiness to use our existing technologies across a broader range of applications, leveraging the core competencies that Novozymes has developed within industrial enzymes.


Microorganisms are a diverse group of microscopic organisms such as fungi, bacteria, and yeasts. They are found everywhere in nature, where they both form and degrade organic materials. Our microorganisms, for instance, are used in industrial and municipal wastewater treatment, as well as to reduce the need for phosphate fertilizer and to improve yields in agriculture.

Biopharmaceutical ingredients

Biopharmaceutical ingredients are proteins and other biological substances used in the pharmaceutical industry. Our proteins replace the proteins from humans and animals that have traditionally been used in the industry. These entail a risk of transferring disease but this is not the case with our proteins, which also offer further advantages such as cost savings. Our biopharmaceutical ingredients offer customers alternative solutions or help them to develop better drugs and devices. For example, hyaluronic acid (HA) products can improve drug delivery and the moisturizing properties of eye drops.


My Report